Getinge Stock

Getinge EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Getinge (GETI B.ST) as of Aug 14, 2026 is 12.86. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 12.01 — a change of 7.07% (higher).

EV/EBIT

12.86

YoY

7.07%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Getinge is 2026 12.86 . EV/EBIT (Enterprise Value to EBIT) of Getinge was 2025 12.01 . It decreases by 7.07% higher compared to the previous year.

The Getinge EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
17.58 base
Jan 1, 2020
10.55 base
Jan 1, 2021
24.09 base
Jan 1, 2022
15.17 base
Jan 1, 2023
14.73 base
Jan 1, 2024
11.03 base
Jan 1, 2025
14.17 base
Jan 1, 2026 (e)
13.12 base
YEARPRICE-TO-EBIT
2026 est 13.12
2025 14.17
2024 11.03
2023 14.73
2022 15.17
2021 24.09
2020 10.55
2019 17.58
2018 -76.63
2017 13.23
2016 10.82
2015 12.90
Access this data via the Eulerpool API

Getinge Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Getinge's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Getinge's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Getinge's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Getinge grows earnings faster than its peers.

Getinge Stock analysis

What does Getinge do? Getinge AB is a globally leading company that offers innovative solutions and products for the healthcare industry. The company was founded in Sweden in 1904 and has since had a long history in the medical technology industry. Getinge AB is known for its leading position in the field of medical equipment, including autoclaves, sterilizers, washer-disinfectors, and ventilators. The business model of Getinge AB is focused on the needs of customers in the healthcare sector. The company operates five business areas: Acute Care Therapies, Infection Control, Extended Care, Life Science, and Surgical Workflows. Each of these business areas focuses on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers innovative and high-quality products and services worldwide. The company promotes continuous innovation and aims to leverage the potential of cutting-edge technologies in the market to develop solutions that improve the lives of patients and healthcare professionals. Various divisions and products - Acute Care Therapies: One of Getinge AB's main products in the Acute Care Therapies area is extracorporeal membrane oxygenation machines (ECMO). These systems are used to support patients with respiratory failure. Another important product line is the Intra-Aortic Balloon Pump (IABP), which is used to support patients with heart failure or cardiogenic shock. - Infection Control: In the Infection Control area, Getinge AB focuses on developing products to control infections that can be caused by hospital environments and medical instruments. This includes sterilization and disinfection devices, as well as cleaning and disinfection agents. - Extended Care: The Extended Care business area offers products and solutions for non-acute patient care. The company focuses on offering innovative products and services that contribute to improving the quality of care and reducing costs. This includes products such as patient beds, mattresses, and assistive devices. - Life Science: In the Life Science area, Getinge AB offers products and services for the biopharmaceutical industry and for research and development. The company specializes in the development of cleanroom technology, which helps make the production of medications safer and more efficient. - Surgical Workflows: The Surgical Workflows business area focuses on optimizing surgical workflows and increasing efficiency. Getinge AB offers products and services such as operating tables, anesthesia and monitoring systems, and wound care products. In summary, Getinge AB has a long history in the medical technology industry and is a leading company in the field. The company operates five business areas that focus on specific needs and requirements within the healthcare sector. Getinge AB aims to offer its customers worldwide innovative and high-quality products and services. The product range includes a wide range of innovative medical technology products, including autoclaves, sterilizers, washer-disinfectors, ventilators, cleaning and disinfection agents, and other medical technology products. Getinge is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Getinge stock

EV/EBIT (Enterprise Value to EBIT) of Getinge is 12.86 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Getinge changed from 12.01 to 12.86, representing a 7.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Getinge since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Getinge with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Getinge

All Key Metrics — Getinge